News | Treatment Planning | November 24, 2015

RaySearch, CERN and INFN Sign Ion Beam Therapy License Agreement

Deal allows RaySearch to incorporate FLUKA algorithm into RayStation treatment planning system for ion beam therapy

November 24, 2015 — CERN, INFN and RaySearch Laboratories AB signed a long-term license agreement in September allowing RaySearch to utilize the FLUKA Monte Carlo code in its research and development in the field of ion beam therapy.

FLUKA is a general purpose tool for calculations of particle transport and interactions with matter, covering an extended range of applications spanning from proton and electron accelerator shielding to target design, calorimetry, activation, dosimetry, detector design, accelerator-driven systems, cosmic rays, neutrino physics and radiation therapy. The FLUKA code has been developed and is maintained by CERN and INFN and represents state-of-the-art in terms of simulation accuracy in areas where hadron interaction physics play an important role.

At RaySearch, the FLUKA code will be an essential tool for research and development in the field of ion beam therapy, which is the most advanced form of external radiation therapy where the tumor is irradiated using, for example, carbon ion beams. Compared to conventional radiation therapy, where the tumor is irradiated using photons, the energy deposition of the ion beams can be controlled more effectively. This means the radiation dose can be delivered even more precisely and, as a result, the unwanted dose to healthy tissues can be reduced, leading to a reduction in treatment-related side effects. In addition, radiation therapy with carbon ions can be used to target tumors with low levels of oxygen, so called hypoxic tumors, for which conventional radiation therapy has limited effect.

By the license agreement concluded, RaySearch is entitled to integrate data generated by the FLUKA code into algorithms of RaySearch’s treatment planning system, RayStation. Ongoing development will comprise a new module for carbon ion treatment optimization, where FLUKA results will be input to pencil beam and Monte Carlo dose engines, and into computations of relative biological effectiveness. The new module will be included in version 5 of RayStation, to be released in December 2015. MedAustron in Wiener Neustadt in Austria and Centro Nazionale di Adroterapia Oncologica (CNAO) in Pavia, Italy, will be the first centers to use RayStation clinically for carbon ion treatment planning.

For more information:

Related Content

Turkish Hospital Begins MR-Guided Radiation Therapy With Viewray MRIdian Linac
News | Image Guided Radiation Therapy (IGRT) | September 21, 2018
ViewRay Inc. announced that Acibadem Maslak Hospital in Istanbul, Turkey has begun treating patients with ViewRay's...
Amar Kishan, M.D.

Amar Kishan, M.D.

News | Prostate Cancer | September 11, 2018
UCLA researchers have discovered that a combination of high doses of...
Videos | Radiation Therapy | September 07, 2018
A discussion with Ehsan Samei, Ph.D., DABR, FAAPM, FSPIE, director of the Duke University Clinical Imaging Physics Gr
Boston Scientific to Acquire Augmenix Inc.
News | Patient Positioning Radiation Therapy | September 07, 2018
Boston Scientific has entered into a definitive agreement to acquire Augmenix Inc., a privately-held company which has...
Non-Canonical Strategy May Improve Cancer Radiotherapy
News | Radiation Therapy | August 29, 2018
August 29, 2018 — Although the success or failure of...
Videos | Treatment Planning | August 28, 2018
A discussion with...
Sponsored Content | Webinar | Radiation Therapy | August 28, 2018
Respiratory tumor motion often complicates the delivery of precision radiation treatment.
Tsuyama Chuo Proton Beam Center Treats First Patients With RayStation
News | Treatment Planning | August 27, 2018
Tsuyama Chuo Hospital in Okayama Prefecture, southwest Japan, has commenced clinical use of RayStation to plan pencil...
Radiation Therapy Affects Event Recall for Children With Brain Tumors
News | Radiation Therapy | August 24, 2018
Children with certain types of brain tumors who undergo radiation treatment are less likely to recall the specifics of...
Videos | Radiation Therapy | August 13, 2018
ITN Editor Dave Fornell takes a tour of some of the innovative new technologies on the expo floor at the 2018 America